CMPI stock forecast
Our latest prediction for Checkmate Pharmaceuticals Inc's stock price was made on the May 12, 2022 when the stock price was at 10.43$.
In the short term (2weeks), CMPI's stock price should underperform the market by -1.98%. During that period the price should oscillate between -11.67% and +12.19%.
In the medium term (3months), CMPI's stock price should outperform the market by 0.29%. During that period the price should oscillate between -38.52% and +28.36%.
Get email alertsCreate a solid portfolio with CMPI
About Checkmate Pharmaceuticals Inc
Checkmate Pharmaceuticals, Inc. operates as a biotechnology company. The Company discovers and develops novel approaches for cancer immunotherapy such as immuno-oncology. Checkmate Pharmaceuticals serves patients worldwide.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -2.84$ per share.
The book value per share is 6.27$
Three months stock forecastMay 12, 2022
Financials
Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|---|---|---|
- | - | -61M | - | -61M | -2.84 | - | - | 22M | 6.27 | -54M | -1M | -55M |